{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v3.3/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Sildenafil",
            "Path": "../../Sildenafil-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "ng/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "IV 20mg"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "IV 25mg"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "IV 40mg"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "IV 50mg"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "IV 80mg"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "Oral solution"
            },
            {
                "SectionReference": "model-verification",
                "Project": "Sildenafil",
                "Simulation": "Tablet MD 20/80mg fasted_Test"
            },
            {
                "SectionReference": "model-verification",
                "Project": "Sildenafil",
                "Simulation": "Tablet MD 20mg fasted_Test"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "Tablet SD 100mg fasted"
            },
            {
                "SectionReference": "model-verification",
                "Project": "Sildenafil",
                "Simulation": "Tablet SD 100mg fasted_Test"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "Tablet SD 20mg fasted"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "Tablet SD 25mg fasted"
            },
            {
                "SectionReference": "model-building",
                "Project": "Sildenafil",
                "Simulation": "Tablet SD 50mg fasted"
            },
            {
                "SectionReference": "model-verification",
                "Project": "Sildenafil",
                "Simulation": "Tablet SD 50mg fasted_Test"
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Sildenafil concentration in plasma",
                "SectionReference": "diagnostics-plots",
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotTypes": [
                    "predictedVsObserved",
                    "residualsOverTime"
                ],
                "Groups": [
                    {
                        "Caption": "Intravenous administration (model building)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Sildenafil",
                                "Simulation": "IV 20mg",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA review, Study 148-203 - 20mg-IV-Infusion - Sildenafil - IV - 20 mg - Plasma - indiv.",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "IV 25mg",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Muirhead 2002b - 25mg-IV-Infusion-Subject 1 - Sildenafil - IV - 25 mg - Plasma - indiv.",
                                    "Muirhead 2002b - 25mg-IV-Infusion-Subject 2 - Sildenafil - IV - 25 mg - Plasma - indiv.",
                                    "Muirhead 2002b - 25mg-IV-Infusion-Subject 3 - Sildenafil - IV - 25 mg - Plasma - indiv."
                                ],
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "IV 40mg",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA review, Study 148-203 - 40mg-IV-Infusion - Sildenafil - IV - 40 mg - Plasma - indiv.",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "IV 50mg",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Nichols 2002 - 50mg-IV-Infusion - Sildenafil - IV - 50 mg - Plasma - agg. (n=12)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "IV 80mg",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "FDA review, Study 148-203 - 80mg-IV-Infusion - Sildenafil - IV - 80 mg - Plasma - indiv.",
                                "Color": "#2166ac"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration, solution (model building)",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Oral solution",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Walker 1999 - 50mg-PO-Solution - Sildenafil - PO - 50 mg - Plasma - agg. (n=3)",
                                "Color": "#2166ac"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration, tablet (model building)",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet SD 100mg fasted",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Nichols 2002 - 100mg-PO-Tablet-Fasted - Sildenafil - PO - 100 mg - Plasma - agg. (n=34)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet SD 20mg fasted",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Spence 2008 - 20mg-PO-Tablet - Sildenafil - PO - 20 mg - Plasma - agg. (n=19)",
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet SD 25mg fasted",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Lee 2021 - Itraconazole DDI, control group - Sildenafil - PO - 25 mg - Plasma - agg. (n=16)",
                                    "Lee 2021 - Clarithromycin DDI, control group - Sildenafil - PO - 25 mg - Plasma - agg. (n=15)"
                                ],
                                "Color": "#2166ac"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet SD 50mg fasted",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Gillen 2017 - Panel 1-50mg-PO-Tablet-Fast - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                                    "Abdelkawy 2016 - 50mg-PO-Tablet - Sildenafil - PO - 50 mg - Plasma - agg. (n=9)",
                                    "Jetter 2002 - 50mg-PO-Tablet - Sildenafil - PO - 50 mg - Plasma - agg. (n=24)",
                                    "Murtadha 2021 - 50mg-PO-Tablet-non smoker - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                                    "Wilner 2002 - 50mg-PO-Tablet-Study I - Sildenafil - PO - 50 mg - Plasma - agg. (n=20)"
                                ],
                                "Color": "#2166ac"
                            }
                        ]
                    },
                    {
                        "Caption": "Oral administration, tablet (model verification)",
                        "Symbol": "SquareOpen",
                        "OutputMappings": [
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet MD 20/80mg fasted_Test",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Burgess 2008 - MD 20mg, 80mg-PO-Tablet - Sildenafil - PO - 20, 80, 80, 0, 20, 80, 80 mg - Plasma - agg. (n=18)",
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet MD 20mg fasted_Test",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Gotzkowsky 2013 - 20mg-PO-Tablet - Sildenafil - PO - 20 mg - Plasma - agg. (n=18)",
                                    "Sidharta 2014 - 20mg-PO-Tablet - Sildenafil - PO - 20 mg - Plasma - agg. (n=12)"
                                ],
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet SD 100mg fasted_Test",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Muirhead 2000 - 100mg-PO-Tablet-Study I - Sildenafil - PO - 100 mg - Plasma - agg. (n=27)",
                                    "Muirhead 2000 - 100mg-PO-Tablet-Study II - Sildenafil - PO - 100 mg - Plasma - agg. (n=28)"
                                ],
                                "Color": "#b2182b"
                            },
                            {
                                "Project": "Sildenafil",
                                "Simulation": "Tablet SD 50mg fasted_Test",
                                "Output": "Organism|PeripheralVenousBlood|Sildenafil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": [
                                    "Wilner 2002 - 50mg-PO-Tablet-Study II - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                                    "Hedaya 2006 - Clarythromycin DDI, control group - Sildenafil - PO - 50 mg - Plasma - agg. (n=12)",
                                    "Gillen 2017 - Panel 2-50mg-PO-Tablet-Fast - Sildenafil - PO - 50 mg - Plasma - agg. (n=11)",
                                    "Al-Ghazawi 2010 - 50mg-PO-Tablet - Sildenafil - PO - 50 mg - Plasma - agg. (n=6)"
                                ],
                                "Color": "#b2182b"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Sildenafil",
            "Name": "Sildenafil",
            "Type": "Compound",
            "SectionReference": "final-input-parameters"
        },
        {
            "Project": "Sildenafil",
            "Name": "Sildenafil Tablet",
            "Type": "Formulation",
            "SectionReference": "final-input-parameters"
        }
    ],
    "Sections": [
        {
            "Reference": "introduction",
            "Title": "Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Reference": "methods",
            "Title": "Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Reference": "modeling-strategy",
                    "Title": "Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Reference": "data",
                    "Title": "Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Reference": "model-parameters-and-assumptions",
                    "Title": "Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Reference": "results-and-discussion",
            "Title": "Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Reference": "final-input-parameters",
                    "Title": "Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Reference": "diagnostics-plots",
                    "Title": "Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Reference": "ct-profiles",
                    "Title": "Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Reference": "model-building",
                            "Title": "Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Reference": "model-verification",
                            "Title": "Model Verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Reference": "conclusion",
            "Title": "Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Reference": "main-references",
            "Title": "References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}